C92.50
Acute myelomonocytic leukemia, not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Acute myelomonocytic leukemia with failed remission
- Acute myelomonocytic leukemia NOS
Medical Intelligence & Overview
ICD-10 code C92.50 refers to a form of blood cancer known as acute myelomonocytic leukemia (AMML), which has not responded to treatment and failed to reach remission. This type of leukemia involves rapid growth of abnormal white blood cells in the bone marrow, leading to their accumulation in the blood and interference with normal blood cell production. When the disease does not go into remission after therapy, it indicates a more aggressive disease course and may require different management approaches.
Causes & Symptoms
Clinical Causes: Genetic mutations acquired over time that affect blood cell development Previous exposure to chemotherapy or radiation therapy Inherited genetic conditions increasing leukemia risk Environmental factors such as exposure to chemicals like benzene Other blood disorders that may predispose to leukemia
Key Symptoms: Frequent infections due to weakened immune response Unusual bleeding or bruising, including nosebleeds or gum bleeding Persistent fatigue and weakness Unintentional weight loss Bone or joint pain Paleness and anemia symptoms Breathlessness or shortness of breath Swelling in lymph nodes or abdomen Fever without an apparent infection
Diagnostic & Treatment
Diagnosis Path: The diagnosis typically involves several tests to confirm the presence of leukemia and assess its severity. These include:
Treatment Protocols: Treating acute myelomonocytic leukemia that has not achieved remission usually requires intensive interventions. Treatment options may involve:
Clinical Advice & FAQs
Billing Guidance
Is C92.50 a billable ICD-10 code?
Yes, C92.50 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.50?
Clinical documentation must specify the nature of Acute myelomonocytic leukemia, not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
